Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1K89
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,192
Award facts
- Contract value 100% obligated
- $14,192.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,192.26 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-unit packages) on November 26, 2025, with an ultimate completion date of November 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies an extensive portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's track record demonstrates consistent capability to fulfill federal procurement requirements through open competition, with previous awards covering diverse therapeutic domains including specialty medications, vaccines, and medical devices. This delivery order for RINVOQ—a rheumatoid arthritis treatment medication—exemplifies the company's role in providing essential pharmaceutical commodities across the military's healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26F1K89?
SPE2DR26F1K89 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F1K89 worth?
The government has obligated $14,192 on SPE2DR26F1K89.
Is contract SPE2DR26F1K89 an order under another contract?
Yes. SPE2DR26F1K89 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1K89 competed?
The extent of competition for SPE2DR26F1K89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award